MedQuist Holdings to Report 2011 Results Consistent with Previous Performance Goals
January 09 2012 - 6:00AM
Business Wire
MedQuist Holdings Inc. (NASDAQ/GS: MEDH), a leading provider of
integrated clinical documentation solutions for the U.S. healthcare
system, announced it expects to report results for the year ended
December 31, 2011, within or above the mid-point of the range of
its 2011 Performance Goals issued on November 9, 2011.
"The strong results we expect to report for 2011 demonstrate the
initial success of the pivot we've made in prioritizing
go-to-market opportunities, contributions from expanding and
enhancing our management team and benefits from our acquisition of
M*Modal combined with a Company-wide commitment to meeting our high
internal expectations," noted Vern Davenport, Chairman and Chief
Executive Officer of MedQuist Holdings. "MedQuist has a unique
opportunity to leverage the transcription industry's largest
customer base with what we believe is the industry's most
innovative and scalable speech and language understanding
technology. The healthcare industry has been very receptive to
solutions we are providing to solve the changing landscape for
clinical documentation.”
Commenting on the expected financial results, Ronald L.
Scarboro, Chief Financial Officer, added, “We finished the year
with the momentum we anticipated and strong execution in all facets
of the business. As we turn to 2012, we are on track with the
initial outlook we provided in mid-November 2011. This plan
anticipates investing our substantial free cash flow to expand our
core transcription business, significantly increase the sales
force, commercialize our speech and language understanding
technologies and fund our growth strategies. Consistent with our
outlook, the benefits from these investments should begin to be
reflected in the second half of 2012 in all key metrics - net
revenues, Adjusted EBITDA and Adjusted Net Income.”
The Company expects to report final results for the year ended
December 31, 2011, on March 7, 2012, with a conference call to
follow on the morning of March 8, 2012. The Company intends to
provide a more detailed outlook for 2012 at that time.
About MedQuist Holdings
MedQuist is a leading provider of clinical narrative capture
services, Speech Understanding technology from M*Modal and clinical
documentation workflow. MedQuist's enterprise solutions – including
mobile voice capture devices, speech recognition, Web-based
workflow platforms and global network of medical editors – help
healthcare facilities facilitate adoption of electronic health
records (EHR), improve patient care, increase physician
satisfaction and lower operational costs. For more information,
please visit www.medquist.com.
Forward-Looking
Statements
Information provided and statements contained in this press
release that are not purely historical, such as statements
regarding our expectations regarding our fiscal 2011 results, our
2012 business plan and the timing of our fiscal 2011 final results
and detailed outlook for 2012, are forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933,
Section 21E of the Securities Exchange Act of 1934 and the Private
Securities Litigation Reform Act of 1995. Such forward-looking
statements only speak as of the date of this press release and the
Company assumes no obligation to update the information included in
this press release. Statements made in this press release that are
forward-looking in nature may involve risks and uncertainties.
Accordingly, readers are cautioned that any such forward-looking
statements are not guarantees of future performance and are subject
to certain risks, uncertainties and assumptions that are difficult
to predict, including, without limitation, specific factors
discussed herein and in other releases and public filings made by
the Company (including filings by the Company with the Securities
and Exchange Commission). Although the Company believes that the
expectations reflected in such forward-looking statements are
reasonable as of the date made, expectations may prove to have been
materially different from the results expressed or implied by such
forward-looking statements. Unless otherwise required by law, the
Company also disclaims any obligation to update its view of any
such risks or uncertainties or to announce publicly the result of
any revisions to the forward-looking statements made in this press
release.
Medx (PK) (USOTC:MEDH)
Historical Stock Chart
From Dec 2024 to Jan 2025
Medx (PK) (USOTC:MEDH)
Historical Stock Chart
From Jan 2024 to Jan 2025